63 results in Exploration of Endocrine and Metabolic Diseases
Latest
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Original Article
Development and validation of a novel risk assessment model for necrotizing fasciitis in patients with diabetic foot
Xun Li ... Qingfeng Cheng
Published: March 12, 2026 Explor Endocr Metab Dis. 2026;3:101463
88 6 0
Open Access Original Article
Fat deposits and their relationship with type 2 diabetes in patients with metabolic syndrome
Ivonne G. Narváez-Ortiz ... Alberto Maceda-Serrano
Published: March 09, 2026 Explor Endocr Metab Dis. 2026;3:101462
147 9 0
Open Access Review
Innovative regenerative genetic and nano therapies for diabetes and metabolic disease
Maria-Kalliopi Spanorriga ... Konstantinos Tsioufis
Published: March 08, 2026 Explor Endocr Metab Dis. 2026;3:101461
306 12 0
Open Access Review
Progesterone for reproductive vitality and women’s healthy ageing
Jerilynn C. Prior, Virginia J. Vitzthum
Published: February 25, 2026 Explor Endocr Metab Dis. 2026;3:101460
This article belongs to the special issue The Fountain of Youth: Decoding the Hormonal Regulation of Aging
1402 44 0
Open Access Commentary
Treating obesity with GLP-1 RAs: does sex matter? A commentary on the meta-analysis by Yang et al. (J Diabetes 2025;17(3):e70063)
Ralf Weiskirchen, Amedeo Lonardo
Published: February 02, 2026 Explor Endocr Metab Dis. 2026;3:101458
1359 23 0
Open Access Review
Impaired cytokines in diabetes and diabetic foot ulcers: mechanisms and prospects
Arbab Alam ... Vikrant Rai
Published: January 21, 2026 Explor Endocr Metab Dis. 2026;3:101457
1672 70 0
Open Access Review
Osteoporosis: definition, diagnosis, and considerations prior to starting treatment
Maritza Vidal, Nancy E. Lane
Published: January 09, 2026 Explor Endocr Metab Dis. 2026;3:101456
2929 51 0
Open Access Meta-Analysis
Association between APOA1 gene (rs670) single-nucleotide polymorphism and dyslipidaemia: a systematic review and meta-analysis
Cauan Farias Ananias ... Tiago Lima Sampaio
Published: January 09, 2026 Explor Endocr Metab Dis. 2026;3:101455
791 32 0
Open Access Review
Cardiovascular effects of endocrine hypertension: insights from primary aldosteronism, pheochromocytoma, and Cushing syndrome
Mehmet Murat Şahin ... Yusuf Karavelioğlu
Published: January 08, 2026 Explor Endocr Metab Dis. 2026;3:101454
1222 55 0
Open Access Review
A novel therapeutic strategy of obesity from the perspective of SPMs
Ze-Wei Zhao
Published: January 05, 2026 Explor Endocr Metab Dis. 2026;3:101453
1134 31 0
Open Access Review
Effects of GLP-1 receptor agonists and dual incretin agonists on adipocyte type and size
Nino Turashvili
Published: December 18, 2025 Explor Endocr Metab Dis. 2025;2:101452
4674 81 0
Open Access Review
Glucocorticoid receptor alpha as a core survival receptor: mechanisms, and implications for health and critical illness
G. Umberto Meduri
Published: December 01, 2025 Explor Endocr Metab Dis. 2025;2:101451
2689 101 1
Open Access Review
Psychotropic medications and metabolic side effects
Michael Natalizio ... Vikrant Rai
Published: November 24, 2025 Explor Endocr Metab Dis. 2025;2:101450
7765 140 0
Open Access Commentary
The pharma race to develop increasingly more potent incretin-based therapeutics—what is for the clinicians to know
Jerzy W Kolaczynski, Eva Surmacz
Published: November 14, 2025 Explor Endocr Metab Dis. 2025;2:101449
2122 118 0
Open Access Original Article
Modeling the progression of NAFLD: a multi-state Markov approach based on BMI classification in the Chinese population
Jianmin Tang ... Xinghua Yang
Published: November 13, 2025 Explor Endocr Metab Dis. 2025;2:101448
1767 34 0
Open Access Review
Hormonal changes during aging and their effects on quality of life
Carter Coggins ... Vikrant Rai
Published: November 10, 2025 Explor Endocr Metab Dis. 2025;2:101447
This article belongs to the special issue The Fountain of Youth: Decoding the Hormonal Regulation of Aging
5866 179 0
Open Access Review
Diabetes mellitus and hepatosteatosis: a narrative review
Mehmet Ali Kosekli
Published: November 10, 2025 Explor Endocr Metab Dis. 2025;2:101446
1607 38 0
Open Access Short Communication
Pharmacological inhibition of type 5 adenylyl cyclase, a model for healthful aging, enhanced exercise capacity and glucose tolerance
Dorothy E. Vatner ... Stephen F. Vatner
Published: November 05, 2025 Explor Endocr Metab Dis. 2025;2:101445
1272 28 0